The Effects of Corneal Collagen Cross-linking
Sponsored by Rush Eye Associates
About this trial
Last updated 3 years ago
Study ID
Rush CXL
Status
Unknown status
Type
Interventional
Phase
Phase 3
Placebo
No
Accepting
10 to 70 Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 8 months ago
What is this trial about?
The corneal collagen cross-linking treatment has been used with increasing success to
treat corneal dystrophies such as "keratoconus." Recent advances have allowed different
techniques for performing this cross-linking treatment. This study investigates the
effects of corneal cross-linking using different surgical techniques.
What are the participation requirements?
Inclusion Criteria
- Age 10-70, willing to participate, diagnosis of corneal ectasia disorder
Exclusion Criteria
- Unwilling or unable to participate in trial
Locations
Location
Status
Recruiting